Titre : Collagène de type V

Collagène de type V : Questions médicales fréquentes

Termes MeSH sélectionnés :

Vascular System Injuries
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Collagène de type V : Questions médicales les plus fréquentes", "headline": "Collagène de type V : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Collagène de type V : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-09", "dateModified": "2025-05-04", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Collagène de type V" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Collagènes fibrillaires", "url": "https://questionsmedicales.fr/mesh/D024022", "about": { "@type": "MedicalCondition", "name": "Collagènes fibrillaires", "code": { "@type": "MedicalCode", "code": "D024022", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.860.300.250.300" } } }, "about": { "@type": "MedicalCondition", "name": "Collagène de type V", "alternateName": "Collagen Type V", "code": { "@type": "MedicalCode", "code": "D024062", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Vera Luiza Capelozzi", "url": "https://questionsmedicales.fr/author/Vera%20Luiza%20Capelozzi", "affiliation": { "@type": "Organization", "name": "Department of Pathology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil." } }, { "@type": "Person", "name": "Ana Paula Pereira Velosa", "url": "https://questionsmedicales.fr/author/Ana%20Paula%20Pereira%20Velosa", "affiliation": { "@type": "Organization", "name": "Division of Rheumatology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil." } }, { "@type": "Person", "name": "Solange Carrasco", "url": "https://questionsmedicales.fr/author/Solange%20Carrasco", "affiliation": { "@type": "Organization", "name": "Division of Rheumatology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil." } }, { "@type": "Person", "name": "David E Birk", "url": "https://questionsmedicales.fr/author/David%20E%20Birk", "affiliation": { "@type": "Organization", "name": "University of South Florida College of Medicine, Tampa, FL 33612, USA." } }, { "@type": "Person", "name": "Lin Han", "url": "https://questionsmedicales.fr/author/Lin%20Han", "affiliation": { "@type": "Organization", "name": "School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, PA 19104, United States. Electronic address: lh535@drexel.edu." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Vascular injury markers associated with cognitive impairment in people with HIV on suppressive antiretroviral therapy.", "datePublished": "2023-07-27", "url": "https://questionsmedicales.fr/article/37503603", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/QAD.0000000000003675" } }, { "@type": "ScholarlyArticle", "name": "External Attention Assisted Multi-Phase Splenic Vascular Injury Segmentation With Limited Data.", "datePublished": "2022-06-01", "url": "https://questionsmedicales.fr/article/34968179", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1109/TMI.2021.3139637" } }, { "@type": "ScholarlyArticle", "name": "Cinematic rendering in the evaluation of complex vascular injury of the lower extremities: how we do it.", "datePublished": "2023-10-28", "url": "https://questionsmedicales.fr/article/37897550", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10140-023-02178-x" } }, { "@type": "ScholarlyArticle", "name": "Correlations Between Preoperative Radiographic Vascular Involvement of Abdominal/Pelvic Neuroblastomas on Computed Tomography and Intraoperative Vascular Injuries: Experience From a Tertiary Children's Hospital.", "datePublished": "2022-10-09", "url": "https://questionsmedicales.fr/article/36220725", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.acra.2022.09.010" } }, { "@type": "ScholarlyArticle", "name": "A Simple Scoring Model for Evaluation of Concomitant Vascular Injuries in Patients with Lower Extremity Open Fractures.", "datePublished": "2022-12-23", "url": "https://questionsmedicales.fr/article/36728899", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/PRS.0000000000010045" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Scléroprotéines", "item": "https://questionsmedicales.fr/mesh/D012596" }, { "@type": "ListItem", "position": 5, "name": "Protéines de la matrice extracellulaire", "item": "https://questionsmedicales.fr/mesh/D016326" }, { "@type": "ListItem", "position": 6, "name": "Collagène", "item": "https://questionsmedicales.fr/mesh/D003094" }, { "@type": "ListItem", "position": 7, "name": "Collagènes fibrillaires", "item": "https://questionsmedicales.fr/mesh/D024022" }, { "@type": "ListItem", "position": 8, "name": "Collagène de type V", "item": "https://questionsmedicales.fr/mesh/D024062" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Collagène de type V - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Collagène de type V", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Collagène de type V", "description": "Comment diagnostiquer une anomalie du collagène de type V ?\nQuels examens sont utilisés pour évaluer le collagène de type V ?\nLes tests sanguins peuvent-ils détecter des problèmes de collagène ?\nQuels symptômes peuvent indiquer un problème de collagène de type V ?\nLe diagnostic précoce est-il important pour le collagène de type V ?", "url": "https://questionsmedicales.fr/mesh/D024062?mesh_terms=Vascular+System+Injuries&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Collagène de type V", "description": "Quels sont les symptômes d'une déficience en collagène de type V ?\nLa fatigue est-elle un symptôme lié au collagène de type V ?\nDes problèmes respiratoires peuvent-ils être liés au collagène de type V ?\nLes troubles de la vision sont-ils associés au collagène de type V ?\nComment les symptômes varient-ils selon l'âge ?", "url": "https://questionsmedicales.fr/mesh/D024062?mesh_terms=Vascular+System+Injuries&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Collagène de type V", "description": "Peut-on prévenir les troubles liés au collagène de type V ?\nL'exercice régulier aide-t-il à maintenir la santé du collagène ?\nLes habitudes alimentaires influencent-elles le collagène ?\nLe tabagisme affecte-t-il la santé du collagène ?\nLe stress a-t-il un impact sur le collagène ?", "url": "https://questionsmedicales.fr/mesh/D024062?mesh_terms=Vascular+System+Injuries&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Collagène de type V", "description": "Quels traitements sont disponibles pour les troubles du collagène de type V ?\nLa thérapie génique est-elle une option pour le collagène de type V ?\nLes suppléments de collagène sont-ils efficaces ?\nLa chirurgie est-elle nécessaire pour traiter les problèmes de collagène ?\nQuels médicaments sont utilisés pour soulager les symptômes ?", "url": "https://questionsmedicales.fr/mesh/D024062?mesh_terms=Vascular+System+Injuries&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Collagène de type V", "description": "Quelles complications peuvent survenir avec des troubles du collagène de type V ?\nLes troubles du collagène peuvent-ils entraîner des problèmes cardiovasculaires ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles réversibles ?\nLes complications peuvent-elles survenir à tout âge ?", "url": "https://questionsmedicales.fr/mesh/D024062?mesh_terms=Vascular+System+Injuries&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Collagène de type V", "description": "Quels sont les facteurs de risque pour les troubles du collagène de type V ?\nL'âge est-il un facteur de risque pour le collagène de type V ?\nLe sexe influence-t-il le risque de troubles du collagène ?\nLes habitudes de vie affectent-elles le risque de troubles du collagène ?\nLes maladies génétiques sont-elles un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D024062?mesh_terms=Vascular+System+Injuries&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une anomalie du collagène de type V ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests génétiques et des biopsies tissulaires." } }, { "@type": "Question", "name": "Quels examens sont utilisés pour évaluer le collagène de type V ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses histologiques et des tests d'imagerie peuvent être utilisés." } }, { "@type": "Question", "name": "Les tests sanguins peuvent-ils détecter des problèmes de collagène ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains marqueurs dans le sang peuvent indiquer des anomalies du collagène." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème de collagène de type V ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs articulaires, des problèmes de peau et des anomalies osseuses peuvent survenir." } }, { "@type": "Question", "name": "Le diagnostic précoce est-il important pour le collagène de type V ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un diagnostic précoce permet une meilleure gestion des symptômes et des complications." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une déficience en collagène de type V ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des douleurs articulaires, des problèmes de peau et des déformations." } }, { "@type": "Question", "name": "La fatigue est-elle un symptôme lié au collagène de type V ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la fatigue peut être un symptôme associé à des troubles du collagène." } }, { "@type": "Question", "name": "Des problèmes respiratoires peuvent-ils être liés au collagène de type V ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies dans le collagène peuvent affecter la fonction pulmonaire." } }, { "@type": "Question", "name": "Les troubles de la vision sont-ils associés au collagène de type V ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines conditions oculaires peuvent être liées à des anomalies du collagène." } }, { "@type": "Question", "name": "Comment les symptômes varient-ils selon l'âge ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent s'aggraver avec l'âge, affectant la mobilité et la peau." } }, { "@type": "Question", "name": "Peut-on prévenir les troubles liés au collagène de type V ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à prévenir certains troubles." } }, { "@type": "Question", "name": "L'exercice régulier aide-t-il à maintenir la santé du collagène ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut renforcer les tissus conjonctifs et améliorer la santé du collagène." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles le collagène ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en vitamine C et en acides aminés favorise la production de collagène." } }, { "@type": "Question", "name": "Le tabagisme affecte-t-il la santé du collagène ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut dégrader le collagène et affecter la santé des tissus conjonctifs." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur le collagène ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut affecter la production de collagène et la santé des tissus." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les troubles du collagène de type V ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la physiothérapie, les médicaments anti-inflammatoires et la chirurgie." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option pour le collagène de type V ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est en cours d'étude pour traiter certaines anomalies du collagène." } }, { "@type": "Question", "name": "Les suppléments de collagène sont-ils efficaces ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les suppléments peuvent aider à améliorer la santé des articulations, mais les preuves varient." } }, { "@type": "Question", "name": "La chirurgie est-elle nécessaire pour traiter les problèmes de collagène ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas, la chirurgie peut être nécessaire pour corriger des déformations." } }, { "@type": "Question", "name": "Quels médicaments sont utilisés pour soulager les symptômes ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des anti-inflammatoires et des analgésiques sont souvent prescrits pour soulager la douleur." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des troubles du collagène de type V ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des déformations osseuses, des douleurs chroniques et des problèmes respiratoires." } }, { "@type": "Question", "name": "Les troubles du collagène peuvent-ils entraîner des problèmes cardiovasculaires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines anomalies du collagène peuvent augmenter le risque de maladies cardiovasculaires." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent réduire la mobilité et causer des douleurs, affectant la qualité de vie." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes." } }, { "@type": "Question", "name": "Les complications peuvent-elles survenir à tout âge ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications peuvent survenir à tout âge, mais elles sont plus fréquentes chez les personnes âgées." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les troubles du collagène de type V ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des maladies auto-immunes et des blessures répétées." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque pour le collagène de type V ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement peut augmenter le risque de troubles liés au collagène." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque de troubles du collagène ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines conditions touchent plus fréquemment les femmes que les hommes." } }, { "@type": "Question", "name": "Les habitudes de vie affectent-elles le risque de troubles du collagène ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes comme le tabagisme et une mauvaise alimentation augmentent le risque." } }, { "@type": "Question", "name": "Les maladies génétiques sont-elles un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies génétiques peuvent prédisposer aux troubles du collagène de type V." } } ] } ] }

Sources (10000 au total)

Vascular injury markers associated with cognitive impairment in people with HIV on suppressive antiretroviral therapy.

Human immunodeficiency virus (HIV)-associated neurocognitive disorders (HAND) remain prevalent despite viral suppression on antiretroviral therapy (ART). Vascular disease contributes to HAND, but peri... Cross-sectional study of vascular injury, inflammation, and central nervous system (CNS) injury markers in relation to HAND.... Vascular injury (VCAM-1, ICAM-1, CRP), inflammation (IFN-γ, IL-1β, IL-6, IL-8, IL-15, IP-10, MCP-1, VEGF-A), and CNS injury (NFL, total Tau, GFAP, YKL-40) markers were measured in plasma and CSF from ... Median age was 53 years, median CD4 + cell count, and duration of HIV infection were 505 cells/μl and 16 years, respectively. Vascular injury, inflammation, and CNS injury markers were increased in HI... Vascular injury markers are more closely related to HAND and CNS injury in PWH on suppressive ART than inflammation markers and may help to distinguish relative contributions of VCI to HAND....

Correlations Between Preoperative Radiographic Vascular Involvement of Abdominal/Pelvic Neuroblastomas on Computed Tomography and Intraoperative Vascular Injuries: Experience From a Tertiary Children's Hospital.

This research examines the prevalence and occurrence of intraoperative vascular injuries in abdominal or pelvic neuroblastomas. It also investigates the correlations between preoperative radiographic ... This study enrolled 297 patients with abdominal or pelvic neuroblastomas. The relationships between neuroblastomas and adjacent arteries on preoperative CT were categorized as no contact, contact (les... A total of 61 patients had intraoperative vascular injuries, among which 76 vessels suffered injuries. Venous injuries (66/76, 86.84%) were more common than arterial injuries (10/76, 13.16%). Moreover... Intraoperative injuries to veins occur more frequently than that to arteries in abdominal or pelvic neuroblastomas. Importantly, intraoperative injuries to veins may occur even if the veins are flatte...

A Simple Scoring Model for Evaluation of Concomitant Vascular Injuries in Patients with Lower Extremity Open Fractures.

Timely diagnosis and management of concomitant vascular injuries is usually needed for the management of lower extremity open fractures. In the current study, a prediction model and simplified scoring... Patients with lower extremity open fractures were retrospectively reviewed from 2017 to 2020. Multivariate logistic regression analysis was used to evaluate independent risk factors for concomitant va... In total, 949 patients with lower extremity open fractures (development cohort, 705 patients, 2017 through 2019; validation cohort, 244 patients, 2020) were enrolled. Concomitant vascular injuries occ... This model may guide the subsequent management of vascular injuries associated with lower extremity open fractures.... Risk, III....

Comparison of treatment and outcomes in blunt thoracic aortic injury based on different vascular surgery guidelines.

Society for Vascular Surgery (SVS) recommendations for managing intimal (grade 1) blunt thoracic aortic injuries (BTAIs) include observation and medical management. University of Washington (UW) revis... We reviewed all patients admitted with BTAI from January 1, 2011, to March 31, 2022. Data included injury grading, demographics, and concomitant traumatic injuries. Images were reviewed to categorize ... Our cohort comprised 208 patients after excluding four who died upon arrival. The mean age was 45 ± 19 years, 69% were men, and the median injury severity score was 34 (interquartile range, 26-45). St... The UW grading system may upgrade or downgrade SVS grade 1 or 2 BTAI for as many as one in six injuries. Upgraded injuries should prompt consideration of repair if there is evidence of flap progressio...

Role of advanced glycation end products in diabetic vascular injury: molecular mechanisms and therapeutic perspectives.

In diabetic metabolic disorders, advanced glycation end products (AGEs) contribute significantly to the development of cardiovascular diseases (CVD).... This comprehensive review aims to elucidate the molecular mechanisms underlying AGE-mediated vascular injury.... We discuss the formation and accumulation of AGEs, their interactions with cellular receptors, and the subsequent activation of signaling pathways leading to oxidative stress, inflammation, endothelia...

Avoiding Compartment Syndrome, Vascular Injury, and Neurologic Deficit in Tibial Osteotomy: An Observational Study of 108 Limbs.

Tibial deformities are common, but substantial concern may be associated with corrective osteotomy regarding major complications reported in classic literature. Such studies chiefly focused on high ti... One hundred eight tibia osteotomies performed during 2019 to 2021 were evaluated, representing all tibia osteotomies except situations of existing infection. A retrospective chart review was performed... The most common osteotomy locations were high tibial osteotomy (35/108 = 32%, 32/35 = 91% medial opening, and 3/35 = 9% medial closing), proximal metaphysis (30/108 = 28%), and diaphysis (32/108 = 30%... Tibial osteotomy can be safely performed for a variety of indications in a diverse range of patients, without a notable risk of the most feared complications of compartment syndrome, vascular injury, ...